Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The SetPoint System Safety & Performance Post-Approval Study (ACTIVATE Study)

NCT07489326 is registered in ClinicalTrials.gov with SetPoint Medical Corporation as lead sponsor.

NCT NCT07489326
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07489326 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The SetPoint System Safety & Performance Post-Approval Study (ACTIVATE Study)
Lead sponsor
SetPoint Medical Corporation
Phase
Observational
Overall status
Not yet recruiting
Start date
April 15, 2026
Completion date
January 1, 2031
Enrollment
150 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis